Medication info
Telotwin Tablet 80/5 mg

Telotwin Tablet 80/5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Youngil Pharmaceutical Co., Ltd.
Appearance
White or off-white rectangular tablet
Packaging
30 tablets/box [(10 tablets/Alu-Alu x 3)]
Approval status
Active

MFDS item code 201901588 · Approved 2019.03.15 · Insurance code 649405170

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with water, regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning), if possible. Before administering this drug, it is recommended to adjust the dose of the individual components (amlodipine or telmisartan); however, if blood pressure is not controlled with an individual component as described below, switching directly to this drug may be considered. - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this drug 40/5 milligrams. - 40/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to begin treatment at a low dose and increase it gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In elderly patients 75 years of age and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
○ Children: Use of this drug is not recommended in pediatric patients 18 years of age or younger, as its safety and efficacy have not been established.

Ingredients

Manufacturer
Youngil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

This medicine helps effectively lower and control blood pressure in patients with essential hypertension whose blood pressure control is insufficient with monotherapy using amlodipine or telmisartan. It is used to manage blood pressure steadily and reduce the risk of cardiovascular diseases.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with water, regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning), if possible. Before administering this drug, it is recommended to adjust the dose of the individual components (amlodipine or telmisartan); however, if blood pressure is not controlled with an individual component as described below, switching directly to this drug may be considered. - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this drug 40/5 milligrams. - 40/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to begin treatment at a low dose and increase it gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In elderly patients 75 years of age and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

○ Children: Use of this drug is not recommended in pediatric patients 18 years of age or younger, as its safety and efficacy have not been established.

Precautions

This drug can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters; therefore, it should not be used by women who are pregnant or may become pregnant. This drug should not be used in patients with certain conditions, such as severely impaired liver function, heart valve disease, severe hypotension, cardiac shock, or unstable heart failure after acute myocardial infarction. Patients with primary aldosteronism, specific heart conditions, liver disorders, gastrointestinal diseases, renal artery hypertension, dialysis patients, and the elderly should use this drug with caution. Dizziness and peripheral edema are common side effects of this drug. Rarely, fainting or severe adverse reactions may occur, so immediate consultation with healthcare professionals is advised if symptoms are severe. This drug should not be taken during pregnancy, and if pregnancy is confirmed, use should be stopped immediately, and alternative treatment should be sought. It is also safe for breastfeeding women not to take this drug. Safety and efficacy for pediatric patients under 18 years of age have not been sufficiently established, and therefore use is not recommended. When administering to the elderly, dosage should be carefully adjusted, and it is recommended to start with a lower dose, especially in those over 75 years old. In case of overdose, symptoms such as hypotension, dizziness, and abnormal heart rate may occur; hence immediate medical attention should be sought. This drug may interact with other medications; therefore, it is essential to inform healthcare professionals if taking other drugs, particularly potassium supplements or diuretics. Dizziness or drowsiness may occur while driving or operating machinery, so caution is advised. This drug contains sorbitol and is not advisable for patients with fructose intolerance. Store in a secure place out of reach of children, and it is best to take it immediately after opening.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 101 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • paresthesia
  • sensory loss
  • dysgeusia
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • double vision
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver function abnormalities
  • liver disorder
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • acute renal failure
  • urination disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin

Not everyone experiences these, and they can vary from person to person.

Storage

This drug is sensitive to light; hence it should be stored in a container that protects it from light. Additionally, the drug should be stored at a temperature between 1 to 30 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

White or off-white rectangular tablet

Package unit

30 tablets/box [(10 tablets/Alu-Alu x 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.